Elyse Visit 1: An Elderly Female with Age-related Macular Degeneration


Elyse Visit 1: An Elderly Female with Age-related Macular Degeneration

Topic: Ophthalmology
Relevant Terms: AMD
Primary Audience: Ophthalmologists and other specialists who care for patients with AMD.
Launch Date: 03-Aug-12
Credits: 0.75 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: AMD in an Elderly Patient with Comorbidities: Diagnosis, Management, and Follow-Up

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Better utilize current therapies for individual patients with AMD.
  2. Identify the roles of new and emerging therapies in the treatment of AMD.
  3. Better utilize monitoring techniques to assess response to therapy in patients with AMD.
  4. Incorporate strategies to adjust individualized treatment protocols to optimize patient response to therapy in AMD.


    David S. Boyer, MD
    Retina-Vitreous Associates Medical Group
    Beverly Hills, CA
    Peter K. Kaiser, MD
    Professor of Ophthalmology
    Chaney Family Chair for Ophthalmology Research
    Cleveland Clinic Lerner College of Medicine
    Case Western Reserve University
    Cleveland, OH
    Michael Ip, MD
    Associate Professor
    Department of Ophthalmology and Visual Sciences, University of Wisconsin
    Co-Director, Fundus Photograph Reading Center
    Madison, WI
    Dr. Boyer discloses that he has served on the advisory boards of Alcon, Allergan, Inc., Genentech, GlaxoSmithKline, Regeneron,  Allegro Ophthalmics, and Novartis. He has also served as a consultant for Alcon, Allergan, Genentech, and Regeneron. He has served on the speakers' bureaus of Allergan and Genentech.

    Dr. Kaiser discloses that he has served on the advisory board of Bausch and Lomb. He has also served as a consultant for Alcon, Regeneron, Bayer, Novartis, Genentech, and Kanghong.

    Dr. Ip discloses that he has served as a consultant for Allergan, Regeneron, and Genentech.

    Rick Ricer, MD, physician reviewer, has no conflicts of interest to disclose.
    Susan P. Tyler, MEd, CCMEP, FACEHP, has no conflicts of interest to disclose.
    Tim Donald, MCM Education medical writer, has no conflicts of interest to disclose.
    Kathleen Hines, MCM Education associate editorial director, has no conflicts of interest to disclose.

    The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of the University of Cincinnati, MCM Education, or the commercial supporter(s). Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.

    This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
    The University of Cincinnati designates this Enduring Material Activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    University of Cincinnati
    Continuing Medical Education
    College of Medicine
    3225 Eden Avenue, G24 Wherry Hall
    Cincinnati, OH 45267
    Phone: 513-558-3132
    Release Date: August 3, 2012
    Expiration Date: August 3, 2013

    This activity has a release date of August 3, 2012 and is valid for 1 year. Requests for credit must be received no later than August 3, 2013.

    A review committee has agreed that this material can be completed in 45 minutes. This estimated study time in turn has determined the credit hours being offered.

    There are no fees for participating in and receiving CME credit for this online educational activity. By reviewing the course content and successfully completing the post-test and evaluation, clinicians are entitled to receive credit. The statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures
    • Participate in the activity
    • Complete the post-test and activity evaluation
    • Clinicians who successfully complete the post-test and evaluation will receive a CME certificate; successful completion is defined as a cumulative score of at least 80% correct
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation
    45 minutes
        Internet Explorer (v7 or greater), Google Chrome, or Firefox
       Safari, Google Chrome, or Firefox

    This activity is supported by an educational grant from Genentech Immunology and Ophthalmology. 

    Commercial Support Guidelines

    If any activity is supported by funds from a commercial source such as a pharmaceutical company or an equipment manufacturer it is very important that the Standards for Commercial Support are followed. In general, commercial entities may support CME activities through unrestricted grants. A commercial supporter may not exert undue influence in the form of determining content, choosing speakers, directly paying honoraria to faculty or paying registration fees of attendees. An acknowledgement of any educational support from a commercial company must appear in program brochures, syllabi, and other program materials.